[9, 22, 23] p16 overexpression in malignant tumors is thought to be a mechanism to overcome proliferation resulting from the failure of the RB1 pathway due to viral infection, genetic/epigenetic silencing of RB1 gene or other mechanism. This evidence concerns the gene CDKN2A and cancer.